Psychosomatic Aspects of Fibromyalgia

Chapter

Abstract

In the field of psychosomatic medicine, there are many patients who report muscle and joint pain. In some patients who report chronic general pain and autonomic dysfunction, the underlying pathological condition is difficult to understand. Fibromyalgia is a chronic pain disorder characterized by long-lasting generalized pain of the fibromuscular system and has historically been studied as a model of chronic pain.

Keywords

Fatigue Depression Serotonin Monoamine Acetaminophen 

Notes

Acknowledgment

Our research was supported in part by the grants from Japanese Ministry of Health, Labor and Welfare for Health Science Research. Authors would like to thank Toshio Matsuno, Ayako Aoki, Mitsuko Isii, Shuichiro Maruoka, and Katsuhiro Miura for technical assistance.

References

  1. 1.
    Murakami, M., Takei, M., Matsukawa, Y., et al. (2004). Psychosomatic approach for fibromyalgia. Clinical Rheumatology and Related Research, 16, 362–367.Google Scholar
  2. 2.
    Murakami, M., Matsuno, T., & Koike, K. (2005). Research on the establishment of disease concept of fibromyalgia syndrome (pp. 162–164). Annual Report on Assigned Research for Health Science Research Grants from the Ministry of Health, Tokyo: Labour and Welfare.Google Scholar
  3. 3.
    Japan College of Fibromyalgia investigation. (2011). Practice Guidelines for Fibromyalgia 2011. Tokyo: Nihon Iji Shimpo.Google Scholar
  4. 4.
    Japan College of Fibromyalgia investigation. (2013). Practice Guidelines for Fibromyalgia 2013. Tokyo: Nihon Iji Shimpo.Google Scholar
  5. 5.
    Wolfe, F., Smythe, H. A., Yunus, M. B., et al. (1990). The american college of rheumatology 1990, criteria for the classification of fibromyalgia. Arthritis and Rheumatism, 33, 160–172.PubMedCrossRefGoogle Scholar
  6. 6.
    Yunus, M. B., Masi, A. T., Aldag, J. C., et al. (1989). Preliminary criteria for primary fibromyalgia syndrome (PFS): Multivariate analysis of a consecutive series of PFS, other patients and normal subjects. Clinical and Experimental Rheumatology, 7, 63–69.PubMedGoogle Scholar
  7. 7.
    Matsumoto, Y., Maeda, S., Tamakoshi, A., et al. (2005). Study on elucidation of the clinical epidemiology of fibromyalgia in Japan (pp. 156–158). Annual Report on Assigned Research for Health Science Research Grants from the Ministry of Health, Tokyo: Labor and Welfare.Google Scholar
  8. 8.
    Wolfe, F., Clauw, D. J., Fitzcharles, M. A., et al. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care & Research, 62, 600–610.CrossRefGoogle Scholar
  9. 9.
    Wolfe, F., & Cathy, M. A. (1983). Prevalence of primary and secondary fibrositis. Journal of Rheumatology, 10, 965–968.PubMedGoogle Scholar
  10. 10.
    Wessely, S., Nimnuan, C., & Sharp, M. (1999). Functional somatic syndrome: One or many ? Lancet, 354, 936–939.PubMedCrossRefGoogle Scholar
  11. 11.
    Murakami, M., Matsuno, T., & Kim, W. (2009). How to evaluate the pain of fibromyalgia syndrome: FMS as a typical model of chronic pain. Japanese Journal of Psychosomatic Medicine, 49, 893–902.Google Scholar
  12. 12.
    Elert, J. E., Rantapää, S. B., Henriksson-larsén, K., et al. (1992). Muscle performance, electromyography and fibre type composition in fibromyalgia and work-related myalgia. Scandinavian Journal of Rheumatology, 21, 28–34.PubMedCrossRefGoogle Scholar
  13. 13.
    Morf, S., Amann-Vesti, B., Forster, A., et al. (2005). Microcirculation abnormalities in patients with fibromyalgia measured by capillary microscopy and laser flowmetry. Arthritis Research & Therapy, 7, R209–R216.CrossRefGoogle Scholar
  14. 14.
    Elvin, A., Siösteen, A. K., Nilsson, A., et al. (2006). Decreased muscle blood flow in fibromyalgia patients during standardized muscle exercise: A contrast media enhanced color doppler study. European Journal of Pain, 10, 137–144.PubMedCrossRefGoogle Scholar
  15. 15.
    Russell, I. J., & Larson, A. A. (2009). Neurophysiopathogenesis of fibromyalgia syndrome: A unified hypothesis. Rheumatic Diseases Clinics of North America, 35, 421–435.PubMedCrossRefGoogle Scholar
  16. 16.
    Reuter, S. E., & Evans, A. M. (2011). Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyl transferase-I activity. Journal of Internal Medicine, 270, 76–84.PubMedCrossRefGoogle Scholar
  17. 17.
    Lesley, M., & Arnold, M. D. (2008). Management of fibromyalgia and comorbid psychiatric disorders. The Journal of Clinical Psychiatry, 69(Suppl. 2), 14–19.Google Scholar
  18. 18.
    Murakami, M., Matsno, T., Kim, W., et al. (2010). Fibromyalgia and negative emotion. Japanese Journal of Psychosomatic Medicine, 50, 1157–1163.Google Scholar
  19. 19.
    Wassem, R., McDonald, M., Racine, J., et al. (2002). Fibromyalgia patient perspectives on symptoms, symptoms management, and provider utilization. Clinical Nurse Specialist, 16, 24–28.PubMedCrossRefGoogle Scholar
  20. 20.
    Fietta, P., Fietta, P., & Manganelli, P. (2007). Fibromyalgia and psychiatric disorders. Acta Bio-Medica, 78, 88–95.PubMedGoogle Scholar
  21. 21.
    Hudson, J. I., Hudson, M. S., Pliner, L. F., et al. (1985). Fibromyalgia and major affective disorder: A controlled phenomenology and family history study. The American Journal of Psychiatry, 142, 441–446.PubMedGoogle Scholar
  22. 22.
    Toru, M., Nakane, Y., & Komiyama, M. (1994). The ICD-10 classification of mental and behavioral disorders (p. 170). Tokyo: Igaku Shoin.Google Scholar
  23. 23.
    Takahashi, S., Ono, Y., & Someya, T. (1995). Quick reference to the diagnostic criteria from DSM-IV. Tokyo: Igaku Shoin.Google Scholar
  24. 24.
    Reilly, P. A., & Littlejohn, G. O. (1990). Current thinking on fibromyalgia syndrome. Australian Family Physician, 19, 1505–1516.PubMedGoogle Scholar
  25. 25.
    Häuser, W., Thieme, K., & Turk, D. C. (2010). Guidelines on the management of fibromyalgia syndrome – a systematic review. European Journal of Pain, 14, 5–10.PubMedCrossRefGoogle Scholar
  26. 26.
    Carette, S., McCain, G. A., Bell, D. A., et al. (1986). Evaluation of amitriptyline in primary fibrositis. Arthritis and Rheumatism, 29, 655–659.PubMedCrossRefGoogle Scholar
  27. 27.
    O’Malley, P. G., Balden, E., Tomkins, G., et al. (2000). Treatment of fibromyalgia with antidepressants: A meta-analysis. Journal of General Internal Medicine, 15, 659–661.PubMedCrossRefGoogle Scholar
  28. 28.
    Arnold, L. M., Keck, P. E., Jr., Welge, J. A., et al. (2000). Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics, 41, 104–113.PubMedCrossRefGoogle Scholar
  29. 29.
    Dooley, D. J., Taylor, C. P., Donevan, S., et al. (2007). Ca2+ channel alpha 2 delta ligands: Novel modulators of neurotransmission. Trends in Pharmacological Sciences, 28, 75–82.PubMedCrossRefGoogle Scholar
  30. 30.
    Crofford, L. J., Rowbotham, M. C., Mease, P. J., et al. (2005). Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double blind, placebo-controlled trial. Arthritis and Rheumatism, 52, 1264–1273.PubMedCrossRefGoogle Scholar
  31. 31.
    Bennett, R. M., Kamin, M., Karim, R., et al. (2003). Tramadol and acetoaminophen combination tablets in the treatment of fibromyalgia pain: A double-blind, randomized placebo-­controlled study. American Journal of Medicine, 114, 537–545.PubMedCrossRefGoogle Scholar
  32. 32.
    Nakamura, H., Hoshi, K., Kato, T., et al. (2003). Clinical feature of fibromyalgia syndrome in Japan and novel strategy in the treatment by bioproduct (Neurotropin). Arthritis Research & Therapy, 5(Suppl. 3), 170.CrossRefGoogle Scholar
  33. 33.
    Murakami, M. (2008). Therapeutic evidence of Kampo treatment for psychosomatic diseases and stress related diseases. Journal of Japanese Association of Oriental Psychosomatic Medicine, 23, 100–102.Google Scholar
  34. 34.
    Goldenberg, D. L., Burckhardt, C., Crofford, L., et al. (2004). Management of fibromyalgia syndrome. Journal of the American Medical Association, 292, 2388–2395.PubMedCrossRefGoogle Scholar
  35. 35.
    Wang, C., Schmid, C. H., & Rones, R. (2011). A randomized trial of tai chi for fibromyalgia. The New England Journal of Medicine, 363, 743–754.CrossRefGoogle Scholar
  36. 36.
    Rossy, L. A., Buckelew, S. P., Dorr, N., et al. (1999). A meta-analysis of fibromyalgia treatment intervention. Annals of Behavioral Medicine, 21, 180–191.PubMedCrossRefGoogle Scholar
  37. 37.
    Goldenberg, D. L., Burckhard, C., Crofford, L., et al. (2004). Management of fibromyalgia syndrome. Journal of the American Medical Association, 292, 2388–2395.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Psychosomatic Internal MedicineNihon University HospitalTokyoJapan
  2. 2.Clinical Psychology, College of Nursing Art and ScienceUniversity of HyogoAkashiJapan

Personalised recommendations